Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipopolysaccharides | 10 | 2014 | 220 | 0.640 |
Why?
|
| Sepsis | 3 | 2010 | 80 | 0.490 |
Why?
|
| Escherichia coli Infections | 2 | 2012 | 41 | 0.480 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2014 | 62 | 0.470 |
Why?
|
| Neutrophils | 2 | 2012 | 131 | 0.470 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2012 | 27 | 0.440 |
Why?
|
| Papio | 1 | 2012 | 22 | 0.430 |
Why?
|
| Pan troglodytes | 1 | 2012 | 21 | 0.430 |
Why?
|
| Chemokine CXCL2 | 1 | 2012 | 11 | 0.420 |
Why?
|
| Chemokine CXCL1 | 1 | 2012 | 15 | 0.420 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 147 | 0.340 |
Why?
|
| Cell Movement | 2 | 2012 | 571 | 0.340 |
Why?
|
| Bacterial Capsules | 1 | 2007 | 6 | 0.310 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2007 | 12 | 0.310 |
Why?
|
| Signal Transduction | 3 | 2012 | 1908 | 0.300 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 132 | 0.280 |
Why?
|
| Mice, Knockout | 14 | 2014 | 933 | 0.280 |
Why?
|
| Immunity, Innate | 5 | 2014 | 149 | 0.260 |
Why?
|
| Escherichia coli | 1 | 2007 | 453 | 0.240 |
Why?
|
| Antigens, CD | 4 | 2010 | 121 | 0.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2009 | 356 | 0.230 |
Why?
|
| Mice | 17 | 2014 | 5913 | 0.230 |
Why?
|
| Shock, Septic | 3 | 2010 | 20 | 0.210 |
Why?
|
| Animals | 20 | 2014 | 15081 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 9 | 2014 | 661 | 0.190 |
Why?
|
| Membrane Glycoproteins | 5 | 2014 | 211 | 0.180 |
Why?
|
| Inflammation | 5 | 2009 | 618 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 1609 | 0.160 |
Why?
|
| Cytokines | 5 | 2012 | 602 | 0.130 |
Why?
|
| Mice, Mutant Strains | 2 | 2012 | 80 | 0.130 |
Why?
|
| Macrophages | 4 | 2005 | 439 | 0.120 |
Why?
|
| Intussusception | 1 | 2014 | 4 | 0.120 |
Why?
|
| Gastrointestinal Motility | 1 | 2014 | 18 | 0.120 |
Why?
|
| Antibodies | 3 | 2010 | 141 | 0.120 |
Why?
|
| Receptors, Cell Surface | 3 | 2005 | 144 | 0.120 |
Why?
|
| Chlorides | 1 | 2014 | 56 | 0.120 |
Why?
|
| Terminology as Topic | 3 | 2002 | 34 | 0.120 |
Why?
|
| Ape Diseases | 1 | 2012 | 4 | 0.110 |
Why?
|
| Monkey Diseases | 1 | 2012 | 6 | 0.110 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 20 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2012 | 43 | 0.100 |
Why?
|
| Species Specificity | 1 | 2012 | 245 | 0.100 |
Why?
|
| Apoptosis | 3 | 2010 | 1398 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 610 | 0.100 |
Why?
|
| Chemokines | 1 | 2012 | 97 | 0.100 |
Why?
|
| Endotoxemia | 2 | 2009 | 5 | 0.100 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 171 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 1015 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2009 | 325 | 0.090 |
Why?
|
| Colony Count, Microbial | 2 | 2007 | 66 | 0.090 |
Why?
|
| Mice, Inbred C3H | 5 | 2009 | 84 | 0.080 |
Why?
|
| Acute-Phase Proteins | 2 | 2014 | 14 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2009 | 39 | 0.080 |
Why?
|
| Milk Proteins | 1 | 2009 | 29 | 0.080 |
Why?
|
| Peptidoglycan | 2 | 2009 | 7 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 186 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 202 | 0.080 |
Why?
|
| Legionella pneumophila | 1 | 2007 | 2 | 0.080 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2007 | 3 | 0.080 |
Why?
|
| Acanthamoeba | 1 | 2007 | 5 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 92 | 0.080 |
Why?
|
| Lipid A | 1 | 2007 | 7 | 0.080 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 35 | 0.080 |
Why?
|
| Kupffer Cells | 2 | 2009 | 2 | 0.080 |
Why?
|
| Animal Structures | 1 | 2007 | 14 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 97 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2007 | 166 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2009 | 435 | 0.070 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2007 | 149 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2007 | 153 | 0.070 |
Why?
|
| Liver | 1 | 2009 | 479 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 628 | 0.070 |
Why?
|
| Gram-Negative Bacteria | 1 | 2005 | 22 | 0.070 |
Why?
|
| Leukocytes | 2 | 2002 | 72 | 0.060 |
Why?
|
| Lyme Disease | 1 | 2005 | 16 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2005 | 212 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 357 | 0.060 |
Why?
|
| Borrelia burgdorferi | 1 | 2005 | 17 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 57 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2006 | 217 | 0.060 |
Why?
|
| HMGB1 Protein | 1 | 2004 | 29 | 0.060 |
Why?
|
| Ligands | 1 | 2005 | 349 | 0.060 |
Why?
|
| Immunity, Mucosal | 1 | 2004 | 47 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2006 | 362 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2005 | 492 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2005 | 123 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 540 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2002 | 85 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2002 | 63 | 0.050 |
Why?
|
| Humans | 7 | 2012 | 37093 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2002 | 90 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 237 | 0.050 |
Why?
|
| Toll-Like Receptors | 3 | 2005 | 51 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2009 | 1518 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2014 | 305 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2009 | 1207 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2009 | 95 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2009 | 24 | 0.030 |
Why?
|
| Spleen | 2 | 2009 | 199 | 0.030 |
Why?
|
| Male | 6 | 2014 | 20025 | 0.030 |
Why?
|
| Manganese Compounds | 1 | 2014 | 16 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 150 | 0.030 |
Why?
|
| Cell Line | 2 | 2009 | 1354 | 0.030 |
Why?
|
| Female | 6 | 2014 | 20969 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 1371 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 1742 | 0.020 |
Why?
|
| NF-kappa B | 2 | 2004 | 339 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 290 | 0.020 |
Why?
|
| Ligation | 1 | 2009 | 10 | 0.020 |
Why?
|
| Punctures | 1 | 2009 | 4 | 0.020 |
Why?
|
| Isoindoles | 1 | 2009 | 18 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2009 | 66 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 31 | 0.020 |
Why?
|
| Cecum | 1 | 2009 | 16 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2009 | 111 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2009 | 75 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 77 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2009 | 110 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2009 | 43 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2009 | 69 | 0.020 |
Why?
|
| Imidazoles | 1 | 2009 | 126 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 191 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2007 | 6 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 444 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2007 | 18 | 0.020 |
Why?
|
| Heart Rate | 1 | 2009 | 253 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2007 | 23 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 90 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 623 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 997 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2007 | 113 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 2006 | 2 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2007 | 399 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 30 | 0.020 |
Why?
|
| Nitrites | 1 | 2006 | 46 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1568 | 0.020 |
Why?
|
| Nitrates | 1 | 2006 | 40 | 0.020 |
Why?
|
| Gene Expression | 1 | 2009 | 674 | 0.020 |
Why?
|
| Biofilms | 1 | 2007 | 168 | 0.020 |
Why?
|
| Computational Biology | 1 | 2007 | 293 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2005 | 4 | 0.020 |
Why?
|
| Ionomycin | 1 | 2004 | 10 | 0.020 |
Why?
|
| COS Cells | 1 | 2004 | 69 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 400 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2004 | 45 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2004 | 5 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 48 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2004 | 81 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 103 | 0.010 |
Why?
|
| Spermine | 1 | 2004 | 64 | 0.010 |
Why?
|
| Streptococcus pyogenes | 1 | 2004 | 27 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2004 | 76 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 35 | 0.010 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 2002 | 5 | 0.010 |
Why?
|
| P-Selectin | 1 | 2002 | 7 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 2002 | 47 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 1095 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2002 | 21 | 0.010 |
Why?
|
| Microcirculation | 1 | 2002 | 37 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2002 | 80 | 0.010 |
Why?
|
| Aerosols | 1 | 2002 | 48 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 124 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2002 | 112 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 115 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 91 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 81 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 433 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 238 | 0.010 |
Why?
|
| Goals | 1 | 2002 | 30 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 128 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 61 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 578 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2002 | 110 | 0.010 |
Why?
|
| Cell Communication | 1 | 2002 | 97 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3483 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2002 | 111 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1039 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 325 | 0.010 |
Why?
|
| Skin | 1 | 2002 | 174 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 480 | 0.010 |
Why?
|
| Myocardium | 1 | 2002 | 235 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 282 | 0.010 |
Why?
|
| Lung | 1 | 2002 | 446 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2231 | 0.010 |
Why?
|